BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26254350)

  • 1. Suppressor microRNA-145 Is Epigenetically Regulated by Promoter Hypermethylation in Esophageal Squamous Cell Carcinoma.
    Harada K; Baba Y; Ishimoto T; Kosumi K; Tokunaga R; Izumi D; Ohuchi M; Nakamura K; Kiyozumi Y; Kurashige J; Iwagami S; Miyamoto Y; Sakamoto Y; Yoshida N; Oki E; Watanabe M; Baba H
    Anticancer Res; 2015 Sep; 35(9):4617-24. PubMed ID: 26254350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
    Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
    Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling.
    Liu R; Gu J; Jiang P; Zheng Y; Liu X; Jiang X; Huang E; Xiong S; Xu F; Liu G; Ge D; Chu Y
    Clin Cancer Res; 2015 Feb; 21(4):854-63. PubMed ID: 25512445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG island methylation status of miRNAs in esophageal squamous cell carcinoma.
    Chen X; Hu H; Guan X; Xiong G; Wang Y; Wang K; Li J; Xu X; Yang K; Bai Y
    Int J Cancer; 2012 Apr; 130(7):1607-13. PubMed ID: 21547903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.
    He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S
    Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of TIP30 in esophageal squamous cell carcinoma cells involves promoter methylation and microRNA-10b.
    Dong W; Shen R; Cheng S
    Biochem Biophys Res Commun; 2014 Oct; 453(4):772-7. PubMed ID: 25312779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients.
    Kuo IY; Chang JM; Jiang SS; Chen CH; Chang IS; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
    Int J Med Sci; 2014; 11(8):779-87. PubMed ID: 24936140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant DNA hypermethylation reduces the expression of the desmosome-related molecule periplakin in esophageal squamous cell carcinoma.
    Otsubo T; Hagiwara T; Tamura-Nakano M; Sezaki T; Miyake O; Hinohara C; Shimizu T; Yamada K; Dohi T; Kawamura YI
    Cancer Med; 2015 Mar; 4(3):415-25. PubMed ID: 25583674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Cui J; Guo Y; Shen S; Guo X; Kuang G
    Clin Exp Metastasis; 2016 Jan; 33(1):73-85. PubMed ID: 26482475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic changes within the promoter regions of antigen processing machinery family genes in Kazakh primary esophageal squamous cell carcinoma.
    Sheyhidin I; Hasim A; Zheng F; Ma H
    Asian Pac J Cancer Prev; 2014; 15(23):10299-306. PubMed ID: 25556465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.
    Yamashita K; Kim MS; Park HL; Tokumaru Y; Osada M; Inoue H; Mori M; Sidransky D
    Mol Cancer Res; 2008 Jan; 6(1):31-41. PubMed ID: 18234960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.
    Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X
    Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant promoter methylation of the TPEF gene in esophageal squamous cell carcinoma.
    Zhao BJ; Tan SN; Cui Y; Sun DG; Ma X
    Dis Esophagus; 2008; 21(7):582-8. PubMed ID: 19040536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma.
    Yue D; Fan Q; Chen X; Li F; Wang L; Huang L; Dong W; Chen X; Zhang Z; Liu J; Wang F; Wang M; Zhang B; Zhang Y
    Exp Cell Res; 2014 Mar; 322(1):149-58. PubMed ID: 24269829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
    Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylation-mediated downregulation of long noncoding RNA LOC100130476 correlates with malignant progression of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Shi Y; Liu S; Liang J; Guo Y; Guo X; Shen S; Shan B
    Dig Liver Dis; 2016 Aug; 48(8):961-9. PubMed ID: 27338851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer.
    Dong Z; Zhang A; Liu S; Lu F; Guo Y; Zhang G; Xu F; Shi Y; Shen S; Liang J; Guo W
    Mol Cancer Res; 2017 Jul; 15(7):800-810. PubMed ID: 28539329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherens junctions associated protein 1 serves as a predictor of recurrence of squamous cell carcinoma of the esophagus.
    Tanaka H; Kanda M; Koike M; Iwata N; Shimizu D; Ezaka K; Sueoka S; Tanaka Y; Takami H; Hashimoto R; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
    Int J Oncol; 2015 Nov; 47(5):1811-8. PubMed ID: 26397940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma.
    Zhao BJ; Sun DG; Zhang M; Tan SN; Ma X
    Dis Esophagus; 2009; 22(1):55-61. PubMed ID: 18564167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic Repression of miR-218 Promotes Esophageal Carcinogenesis by Targeting ROBO1.
    Yang M; Liu R; Li X; Liao J; Pu Y; Pan E; Wang Y; Yin L
    Int J Mol Sci; 2015 Nov; 16(11):27781-95. PubMed ID: 26610476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.